These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36304500)

  • 1. Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update.
    Fouda S; Vennikandam MM; Pappachan JM; Fernandez CJ
    J Clin Transl Hepatol; 2022 Oct; 10(5):947-954. PubMed ID: 36304500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives.
    Zhang Y; Bu Y; Zhao R; Han C
    Ther Adv Endocrinol Metab; 2024; 15():20420188241274350. PubMed ID: 39350947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review.
    Leca BM; Lagojda L; Kite C; Karteris E; Kassi E; Randeva HS; Kyrou I
    Expert Rev Endocrinol Metab; 2024 Jul; 19(4):335-348. PubMed ID: 38860684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of metabolic associated fatty liver detected by FibroScan® in women with gestational diabetes in a multiethnic population.
    Deng D; George J; Pasupathy D; Wah Cheung N
    Diabetes Res Clin Pract; 2021 Apr; 174():108757. PubMed ID: 33744378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis.
    Dyah AA; Rahadina R
    Clin Exp Hepatol; 2021 Sep; 7(3):305-311. PubMed ID: 34712833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy and Metabolic-Associated Fatty Liver Disease.
    Mandato C; Panera N; Alisi A
    Endocrinol Metab Clin North Am; 2023 Sep; 52(3):521-531. PubMed ID: 37495342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty liver with metabolic disorder, such as metabolic dysfunction-associated fatty liver disease, indicates high risk for developing diabetes mellitus.
    Miyake T; Matsuura B; Furukawa S; Ishihara T; Yoshida O; Miyazaki M; Watanebe K; Shiomi A; Nakaguchi H; Yamamoto Y; Koizumi Y; Tokumoto Y; Hirooka M; Takeshita E; Kumagi T; Abe M; Ikeda Y; Iwata T; Hiasa Y
    J Diabetes Investig; 2022 Jul; 13(7):1245-1252. PubMed ID: 35167194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early-Life Exposure to Famine and Risk of Metabolic Associated Fatty Liver Disease in Chinese Adults.
    Liu J; Wang G; Wu Y; Guan Y; Luo Z; Zhao G; Jiang Y
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAFLD and MAFLD as emerging causes of HCC: A populational study.
    Myers S; Neyroud-Caspar I; Spahr L; Gkouvatsos K; Fournier E; Giostra E; Magini G; Frossard JL; Bascaron ME; Vernaz N; Zampaglione L; Negro F; Goossens N
    JHEP Rep; 2021 Apr; 3(2):100231. PubMed ID: 33748726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current perspectives on the pathophysiology of metabolic associated fatty liver disease: are macrophages a viable target for therapy?
    Kjær MB; George J; Kazankov K; Grønbæk H
    Expert Rev Gastroenterol Hepatol; 2021 Jan; 15(1):51-64. PubMed ID: 32878486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Dysfunction-associated Fatty Liver Disease and Mortality Among Chinese Adults: a Prospective Cohort Study.
    Wang X; Wu S; Yuan X; Chen S; Fu Q; Sun Y; Lan Y; Hu S; Wang Y; Lu Y; Qu S; Wang L
    J Clin Endocrinol Metab; 2022 Jan; 107(2):e745-e755. PubMed ID: 34467980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of metabolic syndrome and metabolic dysfunction-associated fatty liver disease on cardiovascular risk by the presence or absence of type 2 diabetes and according to sex.
    Matsubayashi Y; Fujihara K; Yamada-Harada M; Mitsuma Y; Sato T; Yaguchi Y; Osawa T; Yamamoto M; Kitazawa M; Yamada T; Kodama S; Sone H
    Cardiovasc Diabetol; 2022 Jun; 21(1):90. PubMed ID: 35655263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Open Issues in the Transition from NAFLD to MAFLD: The Experience of the Plinio Study.
    Baratta F; Ferro D; Pastori D; Colantoni A; Cocomello N; Coronati M; Angelico F; Del Ben M
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic associated fatty liver disease: Addressing a new era in liver transplantation.
    Gill MG; Majumdar A
    World J Hepatol; 2020 Dec; 12(12):1168-1181. PubMed ID: 33442446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease.
    Wu T; Ye J; Shao C; Li F; Lin Y; Ma Q; Wang W; Feng S; Zhong B
    Front Endocrinol (Lausanne); 2021; 12():691556. PubMed ID: 34899591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality.
    Semmler G; Wernly S; Bachmayer S; Leitner I; Wernly B; Egger M; Schwenoha L; Datz L; Balcar L; Semmler M; Stickel F; Niederseer D; Aigner E; Datz C
    J Clin Endocrinol Metab; 2021 Aug; 106(9):2670-2677. PubMed ID: 33982065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic developments in metabolic dysfunction-associated fatty liver disease.
    Shi Y; Fan J
    Chin Med J (Engl); 2022 May; 135(9):1009-1018. PubMed ID: 35234696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Ke Y; Liu S; Zhang Z; Hu J
    Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of MAFLD and NAFLD diagnostic criteria in real world.
    Lin S; Huang J; Wang M; Kumar R; Liu Y; Liu S; Wu Y; Wang X; Zhu Y
    Liver Int; 2020 Sep; 40(9):2082-2089. PubMed ID: 32478487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.